NCT04409652 is a NA clinical trial of Head on bed in Gallbladder Diseases, sponsored by Ajou University School of Medicine.

Who is sponsoring NCT04409652?

NCT04409652 is sponsored by Ajou University School of Medicine.

What drugs are being tested in NCT04409652?

Interventions in NCT04409652: Head on bed, Head on pillow.

What condition does NCT04409652 study?

NCT04409652 studies Gallbladder Diseases.

Is NCT04409652 still recruiting?

NCT04409652 is currently completed. Last updated 9 November 2023.

Last reviewed 2023-11-09 · How we verify

NCT04409652

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Head Position on Preventing Emergence Cough

Completed NA Last updated 9 November 2023

What this trial tests

NA trial testing Head on bed in Gallbladder Diseases in 72 participants. Completed in 31 December 2022.

Timeline

2 June 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Ajou University School of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	72
Start date	2 June 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across South Korea

Drugs / interventions tested

Head on bed
Head on pillow

Conditions studied

Gallbladder Diseases — all drugs for Gallbladder Diseases →

Sponsor

Ajou University School of Medicine

Who can join

Adults 19 to 85, male only, with Gallbladder Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effect of head position on prevent the emergence cough followed by endotracheal extubation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Impact of Head Elevation on Prevalence and Severity of Emergence Cough in Male Patients during Endotracheal Extubation.
Lim GM, Park SJ, Park SY, Kim JH, et al · · 2023 · PMID 38031390 · DOI 10.12659/msm.942597

Verify or expand the search:

Other Ajou University School of Medicine trials

Trials by the same sponsor.

NCT07101380 — Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients · NA · recruiting
NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
NCT06964217 — Immediate Fracture Risk After Antihypertensive Drug Initiation · not yet recruiting
NCT05751603 — Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex · NA · not yet recruiting
NCT07479160 — Heart to Heart Web-based Communication Program for Heart Failure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04409652 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajou University School of Medicine
Last refreshed: 9 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04409652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing